Registration is now open:

    CR&T's 13th International Patient Symposium on Myeloproliferative Neoplasms (MPNs)

    Cancer Research & Treatment Fund (CR&T) is proud to host the 13th International Patient Symposium for individuals with myeloproliferative neoplasms (MPNs), their families, and friends on Wednesday, October 23, 2024, at the Belfer Research Building, Weill Cornell Medicine.

    Patients and guests attending this day-long symposium will learn about the latest research developments and treatment practices from distinguished MPN researchers and physicians. This is a unique opportunity to engage with guest speakers from the most prestigious cancer centers in the world.

    More information is available on the MPN Symposium tab.

    About CR&T

    Who We Are

    In 1968, Richard T. Silver, MD, a prominent hematologist-oncologist, founded the Cancer Research & Treatment Fund (CR&T) with the belief that investing in blood cancer research would lead to important breakthroughs, as well as a better understanding of the biology and treatment of all forms of cancer.  While the focus of the organization is the myeloproliferative neoplasms (MPNs), over the course of its 55-year history, CR&T has awarded more than $17 million in grants to research that has contributed to major advances in the fight against cancer.

    LEARN MORE

    Our Impact

    $ -1 M
    TO FUND
    BLOOD CANCER
    RESEARCH
    $ -1 M
    TO ESTABLISH
    THE DR. RICHARD
    T. SILVER CHAIR
    $ -1 M
    TO DOCTORS
    FOR OTHER
    CANCER RESEARCH

    Drs. Coleman and Leonard
    Pat Battle, Dr. Silver, Raphael Miranda
    Dr. Silver and Raphael Miranda
    Dr. Silver
    Raphael Miranda, Pat Battle,
    Drs. Silver, Leonard, Coleman
    Pat Battle and Dr. Silver
    The Cancer Research & Treatment Fund’s 12th International Patient Symposium on Myeloproliferative Neoplasms held at Weill Cornell Medicine Wednesday, Nov. 1, 2023, in New York. (AP Photo/John Munson)
    The Cancer Research & Treatment Fund’s 12th International Patient Symposium on Myeloproliferative Neoplasms held at Weill Cornell Medicine Wednesday, Nov. 1, 2023, in New York. (AP Photo/John Munson)
    The Cancer Research & Treatment Fund’s 12th International Patient Symposium on Myeloproliferative Neoplasms held at Weill Cornell Medicine Wednesday, Nov. 1, 2023, in New York. (AP Photo/John Munson)
    Untitled design (1)
    GHAITH ABU-ZEINAH, MD
    GHAITH ABU-ZEINAH, MD
    EDWARD P. AMBINDER, MD
    EDWARD P. AMBINDER, MD
    MORTON COLEMAN, MD, FACP
    MORTON COLEMAN, MD, FACP
    JOHN P. LEONARD, MD
    JOHN P. LEONARD, MD
    ANNE MOORE, MD
    ANNE MOORE, MD
    MALCOLM MOORE, DPhil
    MALCOLM MOORE, DPhil
    MARK PASMANTIER, MD
    MARK PASMANTIER, MD
    SHAHIN RAFII, MD
    SHAHIN RAFII, MD
    JOSEPH M. SCANDURA, MD, PhD
    JOSEPH M. SCANDURA, MD, PhD
    ANDREW I. SCHAFER, MD
    ANDREW I. SCHAFER, MD
    DAVID A. SCHEINBERG, MD, PhD
    DAVID A. SCHEINBERG, MD, PhD
    RICHARD T. SILVER, MD, FACP
    RICHARD T. SILVER, MD, FACP
    JERRY L. SPIVAK, MD
    JERRY L. SPIVAK, MD
    ALEXANDER J. SWISTEL, MD
    ALEXANDER J. SWISTEL, MD

    Medical Advisory Board

    At CR&T, our activities and funding objectives are guided by the expertise of a world-class Medical Advisory Board, featuring some of the world’s foremost physician-scientists in cancer treatment research.

    Meet Our MEDICAL ADVISORY BOARD

    Your gift today can help change a cancer patient's life.

    Microscope

    Looking for other ways you can give?

    https://www.crt.org/ways-to-give/